Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Rational Combination Therapy of AML |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD, PhD |
'A' Award Grants |
2013 |
New York |
Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park / Christopher Jewell, PhD |
'A' Award Grants |
2013 |
Maryland |
Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia |
Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD |
'A' Award Grants |
2016 |
New York |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma |
Dana-Farber Cancer Institute / Cigall Kadoch, PhD |
'A' Award Grants |
2017 |
Massachusetts |
Characterizing the Developmental Context of Pediatric Leukemia
|
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
'A' Award Grants |
2022 |
New York |
WWOX as a Signal Mediator in Pediatric Osteosarcoma |
The Ohio State University / Rami Aqeilan |
'A' Award Grants |
2009 |
Ohio |